volume 67 issue 24 pages 21749-21751

Overcoming Resistance to FLT3-ITD Therapeutics

Publication typeJournal Article
Publication date2024-12-12
scimago Q1
wos Q1
SJR1.801
CiteScore11.5
Impact factor6.8
ISSN00222623, 15204804
Abstract
FLT3-ITD (internal tandem duplication) is a key driver of acute myeloid leukemia (AML), and several FDA-approved drugs target this mutant kinase. This Viewpoint describes the discovery of inhibitors targeting point mutants and the development of SILA123, a highly potent and selective type II FLT3 inhibitor. In in vivo studies, SILA-123 significantly suppressed tumor growth in allograft models, demonstrating its potential in treating resistant AML.
Found 
Found 

Top-30

Journals

1
Biomedicine and Pharmacotherapy
1 publication, 50%
European Journal of Medicinal Chemistry
1 publication, 50%
1

Publishers

1
2
Elsevier
2 publications, 100%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Share
Cite this
GOST |
Cite this
GOST Copy
McInnes C. Overcoming Resistance to FLT3-ITD Therapeutics // Journal of Medicinal Chemistry. 2024. Vol. 67. No. 24. pp. 21749-21751.
GOST all authors (up to 50) Copy
McInnes C. Overcoming Resistance to FLT3-ITD Therapeutics // Journal of Medicinal Chemistry. 2024. Vol. 67. No. 24. pp. 21749-21751.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.jmedchem.4c02878
UR - https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02878
TI - Overcoming Resistance to FLT3-ITD Therapeutics
T2 - Journal of Medicinal Chemistry
AU - McInnes, Campbell
PY - 2024
DA - 2024/12/12
PB - American Chemical Society (ACS)
SP - 21749-21751
IS - 24
VL - 67
PMID - 39666851
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_McInnes,
author = {Campbell McInnes},
title = {Overcoming Resistance to FLT3-ITD Therapeutics},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
publisher = {American Chemical Society (ACS)},
month = {dec},
url = {https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02878},
number = {24},
pages = {21749--21751},
doi = {10.1021/acs.jmedchem.4c02878}
}
MLA
Cite this
MLA Copy
McInnes, Campbell. “Overcoming Resistance to FLT3-ITD Therapeutics.” Journal of Medicinal Chemistry, vol. 67, no. 24, Dec. 2024, pp. 21749-21751. https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02878.